Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Clinical trial NCT05633615 · RECRUITING

Trial details

NCT number: NCT05633615
Sponsor: SWOG Cancer Research Network
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma Grade 3b Follicular Lymphoma Primary Mediastinal (Thymic) Large B-Cell Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Transformed Follic Lymph to Diff Large B-Cell Lymphoma Transformed Marg Zone Lymph to Diff Large B-Cell Lymphoma

Start date: 2023-06-12
Primary completion: 2030-06-30
Enrollment: 396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.